Gilead Sciences Inc Stock Ownership

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?
Brett A. PletcherEVPCorp Affairs & Gen Counsel2021-03-111,486$63.36
Merdad ParseyChief Medical Officer2021-03-101,639$63.91
Johanna MercierChief Commercial Officer2021-03-101,435$63.91
Diane E. WilfongSVP Controller & CAO2021-03-10609$63.91
Andrew D. DickinsonChief Financial Officer2021-03-101,771$63.91
Brett A. PletcherEVPCorp Affairs & Gen Counsel2021-03-101,107$63.91
Daniel Patrick OdayChairman & CEO2021-03-105,123$63.91
Daniel Patrick OdayChairman & CEO2021-03-105,123$63.91
Daniel Patrick OdayChairman & CEO2021-03-0124,620$62.46
Andrew D. DickinsonChief Financial Officer2021-02-15364$56.86

1 of 5

GILD insiders have sold more GILD shares than they have bought in the last year

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?
Capital Research Global Investors9.71%121,672,399$7.87BInstitution
Blackrock Inc8.87%111,183,334$7.19BInstitution
Vanguard Group Inc8.20%102,787,017$6.65BInstitution
State Street Corp4.40%55,206,559$3.57BInstitution
Capital International Investors3.71%46,548,996$3.01BInstitution
Capital World Investors3.07%38,534,588$2.49BInstitution
Geode Capital Management LLC1.60%20,078,920$1.30BInstitution
Dodge Cox1.36%17,107,888$1.11BInstitution
Northern Trust Corp1.22%15,243,829$985.67MInstitution
Bank Of New York Mellon Corp1.10%13,806,532$892.73MInstitution

1 of 3

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 77.30% institutional shareholders, 1.02% Gilead Sciences insiders, and 21.68% retail investors. Capital Research Global Investors is the largest individual Gilead Sciences shareholder, owning 121.67M shares representing 9.71% of the company. Capital Research Global Investors's Gilead Sciences shares are currently valued at $7.90B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.